Connection
Thomas Flaig to Estrogen Receptor alpha
This is a "connection" page, showing publications Thomas Flaig has written about Estrogen Receptor alpha.
|
|
Connection Strength |
|
|
|
|
|
0.043 |
|
|
|
-
Yu EY, Hancock ML, Aronson W, Flaig T, Belkoff L, Tutrone R, Taylor R, Hardigan PC, Getzenberg RH. Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2020 12; 18(6):436-443.
Score: 0.043